EICHORCondition: Carcinoma, Non-Small-Cell Lung · Sponsor: Takeda
This study is about a medicine called TAK-788, also known as mobocertinib, given to adults with non-small cell lung cancer. The main aims of this study are to check if there are any side effects from TAK-788, to learn how TAK-788 is processed by the body, and to determine the best dose of TAK-788 to treat this condition. Participants will take TAK-788 capsules with chemotherapy. Participants will continue to take TAK-788 unless they or their doctor decide they should stop this treatment. Participants will take TAK-788 capsules with or without chemotherapy under antidiarrhea prevention to determine the safety of TAK-788 treatment. Non-Asian, non-White participants will take TAK-788 to determine the safety and tolerability of TAK-788 treatment.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Brookwood Medical Center | Birmingham, Alabama, United States | — |
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | — |
| The Oncology Institute of Hope and Innovation - West Tucson | Tucson, Arizona, United States | — |
| City of Hope Comprehensive Cancer Center - Duarte | Duarte, California, United States | — |
| Compassionate Cancer Care - Fountain Valley | Fountain Valley, California, United States | — |
| University of California San Diego Moores Cancer Center | La Jolla, California, United States | — |
| Pacific Shores Medical Group-Long Beach Elm | Long Beach, California, United States | — |
| Cancer and Blood Specialty Clinic | Los Alamitos, California, United States | — |
| University of California Irvine Health Chao Family Comprehensive Cancer Center | Orange, California, United States | — |
| Stanford Cancer Center - Palo Alto | Palo Alto, California, United States | — |
| SLO Oncology and Hematology Health Center | San Luis Obispo, California, United States | — |
| The Oncology Institute of Hope and Innovation | Whittier, California, United States | — |
+ 50 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02716116